Evidence map›Paper›PMID 18724254›Full record

Trial reportJournal of the American Academy of Child and Adolescent Psychiatry2008

Remission status and cortical thickness in childhood-onset schizophrenia.

Deanna K Greenstein, Sarah Wolfe, Peter Gochman, Judith L Rapoport, Nitin Gogtay

Abstract readClinical Trial
In one paragraph

Trial report in Journal of the American Academy of Child and Adolescent Psychiatry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. The neural effects of psychotropic medications in children and adolescents.Child and adolescent psychiatric clinics of North America · 2012
    Review
  9. Article
  10. Article
  11. Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Deanna K GreensteinChild Psychiatry Branch, National Institute of Mental Health/National Institutes of Health, Bethesda, MD 20892-1600, USA. greenstd@mail.nih.gov
Sarah Wolfe
Peter Gochman
Judith L Rapoport
Nitin Gogtay
National Institutes of Health · USNational Institute of Mental Health · US

Funding

Intramural NIH HHS Z99 MH999999
6 · The paper itself

Abstract

objectiveFew studies have examined prediction of schizophrenia outcome in relation to brain magnetic resonance imaging measures. In this study, remission status at the time of discharge was examined in relation to admission cortical thickness for childhood-onset schizophrenia probands. We hypothesized that total, frontal, temporal, and parietal gray matter thickness would be greater in patients who subsequently remit.

methodThe relation between admission cortical brain thickness on magnetic resonance imaging and remission status at the time of discharge an average of 3 months later was examined for 56 individuals (32 males) ages 6 to 19 diagnosed with childhood-onset schizophrenia. Cortical thickness was measured across the cerebral hemispheres at admission. Discharge remission criteria were adapted from the 2005 Remission in Schizophrenia Working Group criteria.

resultsPatients remitted at discharge (n = 16 [29%]) had thicker regional cortex in left orbitofrontal, left superior, and middle temporal gyri and bilateral postcentral and angular gyri (p < or = .008).

conclusionsOur results provide neuroanatomic correlates of clinical remission in schizophrenia and evidence that response to treatment may be mediated by these cortical brain regions.

Indexed as

Image Processing, Computer-AssistedMagnetic Resonance ImagingSchizophrenic PsychologyAdolescentAge of OnsetAntipsychotic AgentsCerebral CortexChildClozapineCombined Modality TherapyDominance, CerebralDouble-Blind MethodDrug Therapy, CombinationFamily TherapyFemaleFrontal LobeAntipsychotic AgentsClozapine

Identifiers

PMID18724254
PMCPMC3430080
OpenAlexW2035028650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.